|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|2018 Korean Heart Rhythm Society Guidelines for Antiarrhythmic Drug Therapy in Non-valvular Atrial Fibrillation|
|Ki-Woon Kang, Jaemin Shim, Jinhee Ahn, Dae In Lee, Jun Kim, Boyoung Joung, Kee-Joon Choi|
|Korean J Med. 2018;93(2):140-152. Published online 2018 April 1 DOI: https://doi.org/10.3904/kjm.2018.93.2.140|
2018 Korean Heart Rhythm Society Guidelines for Antiarrhythmic Drug Therapy in Non-valvular Atrial Fibrillation
ACE I/D polymorphism modulates response to antiarrhythmic drug therapy in patients with atrial fibrillation
To the Editor—Atrial Fibrillation Guidelines
OBSOLETE: Pharmacogenomics of Antiarrhythmic Drug Therapy for Atrial Fibrillation
Nonantiarrhythmic drug therapy for atrial fibrillation
Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?
Non-antiarrhythmic drugs to prevent atrial fibrillation
A 25-year control of idiopathic ventricular fibrillation with electrophysiologic-guided antiarrhythmic drug therapy
Long-term antiarrhythmic drug treatment after atrial fibrillation ablation: does a too obstinate rhythm control strategy bring serious risk of proarrhythmia to ablated patients?
Potassium channels in atrial fibrillation: Targets for atrial and pathology-specific therapy?
|This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Med has participated in CrossRef Text and Data Mining service since September 11, 2015.|